Skip to Content

Brain Scientific Inc BRSF

Morningstar Rating
$0.75 −0.35 (31.82%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BRSF is trading at a 64% discount.
Price
$0.76
Fair Value
$2.74
Uncertainty
Extreme
1-Star Price
$51.81
5-Star Price
$3.17
Economic Moat
Wvlmq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BRSF is a good fit for your portfolio.

Trading Information

Previous Close Price
$1.10
Day Range
$0.750.75
52-Week Range
$0.753.45
Bid/Ask
$0.52 / $1.10
Market Cap
$931,985.25
Volume/Avg
808 / 808

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.32
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees
11

Valuation

Metric
BRSF
Price/Earnings (Normalized)
Price/Book Value
0.22
Price/Sales
3.32
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BRSF
Quick Ratio
0.10
Current Ratio
0.18
Interest Coverage
−2.42
Quick Ratio
BRSF

Profitability

Metric
BRSF
Return on Assets (Normalized)
−44.97%
Return on Equity (Normalized)
−175.23%
Return on Invested Capital (Normalized)
−26.62%
Return on Assets
BRSF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHgtlbpxcFhdbglc$182.7 Bil
SYK
Stryker CorpZncgxjdhQcsf$124.6 Bil
MDT
Medtronic PLCLqjfxwnvGxzvflh$105.0 Bil
BSX
Boston Scientific CorpRdbpyffhLkdcqkq$99.9 Bil
EW
Edwards Lifesciences CorpBnkqbzyfjtTfbwnx$52.0 Bil
DXCM
DexCom IncNfgrvfqzjMry$51.8 Bil
ZBH
Zimmer Biomet Holdings IncThvzymvvdQmgp$24.9 Bil
ALGN
Align Technology IncXlknlzndKsttww$22.6 Bil
PHG
Koninklijke Philips NV ADRFysgsbydhTddznx$18.2 Bil
PODD
Insulet CorpVvwfkqsgZvdctj$11.6 Bil

Sponsor Center